Saskia Smits

Dr. Saskia Smits


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2012 in Emerging Infectious Diseases
Verified
Journal Article
Open access
SSSaskia Smits
Saskia Smits
MRMustafizur Rahman
Mustafizur Rahman
CSClaudia M.E. Schapendonk
Claudia M.E. Schapendonk
MLMarije van Leeuwen
Marije van Leeuwen
AFAbu S.G. Faruque
Abu S.G. Faruque
AOAlbert D.M.E. Osterhaus
Albert D.M.E. Osterhaus
To identify unknown human viruses in the enteric tract, we examined 105 stool specimens from patients with diarrhea in Bangladesh. A novel calicivirus was identified in a sample from 1 patient and subsequently found in samples from 5 other patients. Phylogenetic analyses classified this virus within the proposed genus Recovirus.

1 September 2012 in Emerging Infectious Diseases
Verified
Journal Article
Open access
SSSaskia Smits
Saskia Smits
MLMarije van Leeuwen
Marije van Leeuwen
CSClaudia M.E. Schapendonk
Claudia M.E. Schapendonk
ASAnita C Schürch
Anita C Schürch
RBRogier Bodewes
Rogier Bodewes
AOAlbert D.M.E. Osterhaus
Albert D.M.E. Osterhaus

1 January 2016 in The Pediatric Infectious Disease Journal
Verified
Journal Article
Closed access
SSSaskia Smits
Saskia Smits
AOAlbert D.M.E. Osterhaus
Albert D.M.E. Osterhaus
MKMarion P.G. Koopmans
Marion P.G. Koopmans

2 January 2018 in Viruses
Verified
Journal Article
Open access
PDF file
LWLeon De Waal
Leon De Waal
SSSaskia Smits
Saskia Smits
EKEdwin J.B. Veldhuis Kroeze
Edwin J.B. Veldhuis Kroeze
GAGeert Van Amerongen
Geert Van Amerongen
MPMarie O. Pohl
Marie O. Pohl
KSKoert J. Stittelaar
Koert J. Stittelaar
Human respiratory syncytial virus (HRSV) causes substantial morbidity and mortality in vulnerable patients, such as the very young, the elderly, and immunocompromised individuals of any age. Nosocomial transmission of HRSV remains a serious challenge in hospital settings, with intervention strategies largely limited to infection control measures, including isolation of cases, high standards of hand hygiene, cohort nursing, and use of personal protective equipment. No vaccines against HRSV are currently available, and treatment options are largely supportive care and expensive monoclonal antibody or antiviral therapy. The limitations of current animal models for HRSV infection impede the development of new preventive and therapeutic agents, and the assessment of their potential for limiting HRSV transmission, in particular in nosocomial settings. Here, we demonstrate the efficient transmission of HRSV from immunocompromised ferrets to both immunocompromised and immunocompetent contact ferrets, with pathological findings reproducing HRSV pathology in humans. The immunocompromised ferret-HRSV model represents a novel tool for the evaluation of intervention strategies against nosocomial transmission of HRSV.

5 February 2020 in The American Journal of Tropical Medicine and Hygiene
Verified
Journal Article
Closed access
EZEduard E. Zijlstra
Eduard E. Zijlstra
Jaap van HellemondJaap van Hellemond
Jaap van Hellemond
AMArthur D. Moes
Arthur D. Moes
CBChrista de Boer
Christa de Boer
SBShelley A. Boeschoten
Shelley A. Boeschoten
CRCamilla Rothe
Camilla Rothe
Nontraumatic myelopathy causes severe morbidity and is not uncommon in Africa. Clinically, patients often present with paraplegia, and extrinsic cord compression and transverse myelitis are most common causes. Data on exact pathogenesis are scanty because of limitations in diagnostic methods. In Queen Elizabeth Central Hospital, Blantyre, Malawi, we recorded consecutive patients presenting with nontraumatic paraplegia for maximally 6 months between January and July 2010 and from March to December 2011. The diagnostic workup included imaging and examining blood, stool, urine, sputum, and cerebrospinal fluid (CSF) samples for infection. After discharge, additional diagnostic tests, including screening for virus infections, borreliosis, syphilis, and schistosomiasis, were carried out in the Netherlands. The clinical diagnosis was, thus, revised in retrospect with a more accurate final differential diagnosis. Of 58 patients included, the mean age was 41 years (range, 12–83 years) and the median time between onset and presentation was 18 days (range, 0–121 days), and of 55 patients tested, 23 (42%) were HIV positive. Spinal tuberculosis (n = 24, 41%), tumors (n = 16, 28%), and transverse myelitis (n = 6, 10%) were most common; in six cases (10%), no diagnosis could be made. The additional tests yielded evidence for CSF infection with Schistosoma, Treponema pallidum, EBV, HHV-6, HIV, as well as a novel cyclovirus. The diagnosis of the cause of paraplegia is complex and requires access to an MRI scan and other diagnostic (molecular) tools to demonstrate infection. The major challenge is to confirm the role of detected pathogens in the pathophysiology and to design an effective and affordable diagnostic approach.